A Collaborative Approach to Home OKT3 Infusion Therapy.

Publication/Presentation Date

11-1-1993

Abstract

Hospitalization of patients who have undergone renal transplantation is often extended because of the need to complete complex antirejection infusion therapy. Because of the costs associated with prolonged hospitalization, medical professionals who provide care to these patients are developing programs that will facilitate attainment of quality care in the outpatient setting. The authors describe the effective implementation of a home Muromonab-CD3 (OKT3) intravenous administration program among renal transplant recipients based on thorough planning and close collaboration between the transplant service and home care staff.

Volume

23

Issue

11

First Page

63

Last Page

66

ISSN

0002-0443

Disciplines

Nursing

PubMedID

8229277

Department(s)

Patient Care Services / Nursing

Document Type

Article

Link to Full Text

Share

COinS